Atomic AI
Atomic AI is at the forefront of AI-driven RNA drug discovery, utilizing a proprietary platform that combines machine learning and structural biology to develop RNA-targeted small molecules and RNA-based medicines. The company aims to tackle previously untreatable diseases by engineering RNA biology, supported by a world-class interdisciplinary team with expertise in various scientific fields. Their innovative approach positions them uniquely in the biotech landscape, focusing on the intersection of AI and molecular structure to revolutionize drug discovery.
Atomic AI
Atomic AI is at the forefront of AI-driven RNA drug discovery, utilizing a proprietary platform that combines machine learning and structural biology to develop RNA-targeted small molecules and RNA-based medicines. The company aims to tackle previously untreatable diseases by engineering RNA biology, supported by a world-class interdisciplinary team with expertise in various scientific fields. Their innovative approach positions them uniquely in the biotech landscape, focusing on the intersection of AI and molecular structure to revolutionize drug discovery.
